Volume 2, Issue 12
Editorialp. 1147–114
Clinical trials involving prisoners: a bioethical perspective
Author(s): Kevin Knight, Patrick M Flynn
News and Viewsp. 1151–115
If Big Pharma pay, it can keep the doctor away
Interviewp. 1157–116
Neuroblastoma drug development: from lab bench to bedside?
Author(s): Louis Chesler
Methodologyp. 1163–116
Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial
Author(s): Thomas Kaulhausen
Therapeutic Perspectivep. 1171–117
Kidney transplantation: into the future with belatacept
Author(s): Antoine Durrbach
Therapeutic Perspectivep. 1177–118
The risks and benefits of prophylactic aspirin in vascular disease and cancer
Author(s): Peter C Elwood, Mohammed Mustafa, Maribel Almonte & Gareth Morgan
Special Reportp. 1185–118
Bioabsorbable stents-nothing from something
Author(s): NS Rajendra, BJ Wrigley, AH Gershlick
Clinical Trail Methodologyp. 1191–120
Rationale and methodology for trial-based economic evaluation
Author(s): Stavros Petrou
Review: Clinical Trail Outcomesp. 1201–121
The emerging role of vedolizumab in the treatment of ulcerative colitis
Author(s): Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomesp. 1213–122
Polypill (fixed-dose combinations) in the prevention of cardiovascular disease: rationale and clinical data
Author(s): Kavita Singh, Abdul Salam, Raji Devarajan, Anushka Patel4, Dorairaj Prabhakaran
Review: Clinical Trail Outcomesp. 1231–124
Assessment and management of mucositis in head and neck cancer patients
Author(s): Marcelo Bonomi, Nadia Camille, Krzysztof Misiukiewicz, Asma Latif, Vishal Gupta, Seth Blacksburg, Eric Genden,Marshall Posner
